Emflaza (Deflazacort Oral Suspension) and Moxetumomab Pasudotox-tdfk
Determining the interaction of Emflaza (Deflazacort Oral Suspension) and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deflazacort
Brand name: Emflaza
Synonyms: Emflaza
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emflaza (Deflazacort Oral Suspension)-Moxetumomab pasudotox-tdfk Intravenous
- Emflaza (Deflazacort Oral Suspension)-Moxifloxacin
- Emflaza (Deflazacort Oral Suspension)-Moxifloxacin (Systemic)
- Emflaza (Deflazacort Oral Suspension)-Moxifloxacin Hydrochloride
- Emflaza (Deflazacort Oral Suspension)-Moxifloxacin Injection
- Emflaza (Deflazacort Oral Suspension)-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Emflaza (Deflazacort Tablets)
- Moxetumomab Pasudotox-tdfk-Emicizumab
- Moxetumomab Pasudotox-tdfk-Emicizumab-kxwh
- Moxetumomab Pasudotox-tdfk-Emicizumab-kxwh Subcutaneous
- Moxetumomab Pasudotox-tdfk-Emla
- Moxetumomab Pasudotox-tdfk-Emla Topical